You are here: Industry Insights > cancer

News List

Common cancer treatments do not worsen COVID-19 infection, study finds europeanpharmaceuticalreview
June 30, 2020
A study has found that chemotherapy and surgery do not correlate with worse COVID-19 outcomes for cancer patients, whereas taking immune checkpoint inhibitors does.
FDA announces first of its kind pilot program to communicate patient reported outcomes from cancer clinical trials worldpharmanews
June 29, 2020
The U.S. Food and Drug Administration launched Project Patient Voice, an initiative of the FDA’s Oncology Center of Excellence (OCE).
Research charities warn of funding cuts in coronavirus wake pharmatimes
June 24, 2020
Charities including Cancer Research UK (CR UK) and the British Heart Foundation are warning that research funding will take a substantial hit in the wake of COVID-19 and that this will likely have significant consequences on survival.
Interdisciplinary consortium receives grant to develop next-generation cell-based cancer vaccines pharmaceutical-business-review
June 23, 2020
Cell-based cancer vaccines are revolutionizing the treatment of previously incurable cancers. Access to these promising therapies is limited by the high costs of manufacturing at centralized locations.
Researchers develop highly sensitive blood test for cancer pharmatimes
June 22, 2020
Researchers have developed a new way of analysing cancer patients’ blood for evidence of the disease that could be up to ten times more sensitive than previous methods.
NHS accelerates launch of new radiotherapy pharmatimes
June 16, 2020
NHS England is accelerating the launch of a new type of radiotherapy that requires fewer doses than current approaches, thus cutting the number of hospital visits for potentially vulnerable cancer patients.
AbbVie inks $750m cancer therapeutics deal with Genmab pharmaceutical-technology
June 15, 2020
AbbVie has entered a collaboration agreement with biotechnology company Genmab to develop and commercialise antibody therapeutics for cancer.
Cancer CART therapy: What are the benefits and stakes? expresspharma
June 15, 2020
Debamita Chatterjee, Ex-researcher, Harvard Medical School and NYAS/MIT/European Commission Innovation Mentor elaborates how R&D, regulatory and commercial activities have globally bolstered the technological promise of Cancer CART therapy and ...
NHS waiting lists could hit 10m by year end pharmatimes
June 11, 2020
NHS waiting lists could swell to 10 million by the end of the year, and possibly higher if there is a second wave of COVID-19 and a lack of treatment or a vaccine, the NHS Confederation warns.
Scientists identify targets for COVID-19 vaccine using cancer immunotherapy tools worldpharmanews
June 10, 2020
Cancer researchers at Children's Hospital of Philadelphia (CHOP) have harnessed tools used for the development of cancer immunotherapies and adapted them to identify regions of the SARS-CoV-2 virus to target with a vaccine...

Previous page 1 2 3 4 5 6 7 8 9 10 ... 87 88 Next page